CAMP4 Therapeutics

About:

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Website: https://www.camp4tx.com/

Twitter/X: camp4tx/media

Top Investors: Gaingels, Andreessen Horowitz, Biogen, Enavate Sciences, Polaris Partners

Description:

CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression. Their predictions enables CAMP4 to have a rapid start to disease treatment, significantly reducing the time and risk to bring new medicines to patients.

Total Funding Amount:

$190M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)camp4tx.com

Founders:

Leonard Zon, Richard Young

Number of Employees:

11-50

Last Funding Date:

2022-07-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai